CURRENT PERSPECTIVES ON THE SIGNIFICANCE AND INTERPRETATION OF FACTOR-VIII AND FACTOR-IX INHIBITORS - PANEL DISCUSSION

被引:0
|
作者
LUSHER, J
BRIET, E
KASPER, C
HOYER, L
HOOTS, K
HAY, C
GRUPPO, R
ROBERTS, H
RICKLES, F
MARCINIAK, E
ALEDORT, L
PRESTON, E
KISKER, T
KIM, H
LAURIAN, Y
机构
[1] LEIDEN UNIV HOSP, 2333 AA LEIDEN, NETHERLANDS
[2] ORTHOPED HOSP, LOS ANGELES, CA 90007 USA
[3] AMER RED CROSS, HOLLAND LAB, BETHESDA, MD USA
[4] ROYAL LIVERPOOL HOSP, LIVERPOOL L7 8XP, MERSEYSIDE, ENGLAND
[5] CHILDRENS HOSP MED CTR, CINCINNATI, OH 45229 USA
[6] UNIV N CAROLINA, CHAPEL HILL, NC 27514 USA
[7] MT SINAI MED CTR, NEW YORK, NY 10029 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:63 / 74
页数:12
相关论文
共 50 条
  • [2] INHIBITORS OF FACTOR-VIII AND FACTOR-IX
    BRETTLER, DB
    HAEMOPHILIA, 1995, 1 : 35 - 39
  • [3] FACTOR-VIII AND FACTOR-IX INHIBITORS IN HEMOPHILIACS
    LJUNG, R
    PETRINI, P
    LINDGREN, AC
    TENGBORN, L
    NILSSON, IM
    LANCET, 1992, 339 (8808): : 1550 - 1550
  • [5] TREATMENT OF PATIENTS WITH FACTOR-VIII AND FACTOR-IX INHIBITORS
    NILSSON, IM
    BERNTORP, E
    FREIBURGHAUS, C
    THROMBOSIS AND HAEMOSTASIS, 1993, 70 (01) : 56 - 59
  • [6] INCIDENCE OF DEVELOPMENT OF FACTOR-VIII AND FACTOR-IX INHIBITORS IN HEMOPHILIACS
    EHRENFORTH, S
    KREUZ, W
    SCHARRER, I
    LINDE, R
    FUNK, M
    GUNGOR, T
    KRACKHARDT, B
    KORNHUBER, B
    LANCET, 1992, 339 (8793): : 594 - 598
  • [7] IMMUNOSUPPRESSIVE TREATMENT IN HEMOPHILIACS WITH INHIBITORS TO FACTOR-VIII AND FACTOR-IX
    NILSSON, IM
    HEDNER, U
    SCANDINAVIAN JOURNAL OF HAEMATOLOGY, 1976, 16 (05): : 369 - 382
  • [8] HEMOPHILIA - FACTOR-VIII AND FACTOR-IX
    HOFFMAN, SH
    JOURNAL OF MEDICAL TECHNOLOGY, 1985, 2 (05): : 319 - 320
  • [9] SAFER FACTOR-VIII AND FACTOR-IX
    不详
    LANCET, 1986, 2 (8501): : 255 - 256
  • [10] USE OF FACTOR-VIII AND FACTOR-IX PRODUCTS
    BRITTEN, AFH
    VOX SANGUINIS, 1984, 46 : 12 - 14